Catalog Home Page

Publications: Institute for Immunology and Infectious Diseases

Export as [feed] RSS
Group by: Publication Type | Year
Number of items at this level: 220.

Journal Article

Acikyol, B., Graham, R.M., Trinder, D., House, M.J., Olynyk, J.K., Scott, R.J., Milward, E.A. and Johnstone, D.M. (2013) Brain transcriptome perturbations in the transferrin receptor 2 mutant mouse support the case for brain changes in iron loading disorders, including effects relating to long-term depression and long-term potentiation. Neuroscience, 235 . pp. 119-128.

Adams, L.A., White, S.W., Marsh, J.A., Lye, S.J., Connor, K.L., Maganga, R., Ayonrinde, O.T., Olynyk, J.K., Mori, T.A., Beilin, L.J., Palmer, L.J., Hamdorf, J.M. and Pennell, C.E. (2013) Association between liver-specific gene polymorphisms and their expression levels with nonalcoholic fatty liver disease. Hepatology, 57 (2). pp. 590-600.

Almeida, C.M., Bronke, C., Roberts, S.G., McKinnon, E., Keane, N.M., Chopra, A., Kadie, C., Carlson, J., Haas, D. W., Riddler, S. A., Haubrich, R., Heckerman, D., Mallal, S. and John, M. (2011) Translation of HLA-HIV associations to the cellular level: HIV adapts to inflate CD8 T cell responses against Nef and HLA-adapted variant epitopes. The Journal of Immunology, 187 (5). pp. 2502-2513.

Apps, R., Qi, Y., Carlson, J.M., Chen, H., Gao, X., Thomas, R., Yuki, Y., Del Prete, G.Q., Goulder, P., Brumme, Z.L., Brumme, C.J., John, M., Mallal, S., Nelson, G., Bosch, R., Heckerman, D., Stein, J.L., Soderberg, K.A., Moody, M.A., Denny, T.N., Zeng, X., Fang, J., Moffett, A., Lifson, J.D., Goedert, J.J., Buchbinder, S., Kirk, G.D., Fellay, J., McLaren, P., Deeks, S.G., Pereyra, F., Walker, B., Michael, N.L., Weintrob, A., Wolinsky, S., Liao, W. and Carrington, M. (2013) Influence of HLA-C expression level on HIV control. Science, 340 (6128). pp. 87-91.

Awadalla, P., Carlson, J., Kadie, C., Mallal, S. and Heckerman, D. (2007) Leveraging hierarchical population structure in discrete association studies. PloS one, 2 (7). pp. 1-13.

Balloux, F., McLaren, P.J., Coulonges, C., Ripke, S., van den Berg, L., Buchbinder, S., Carrington, M., Cossarizza, A., Dalmau, J., Deeks, S.G., Delaneau, O., De Luca, A., Goedert, J.J., Haas, D., Herbeck, J.T., Kathiresan, S., Kirk, G.D., Lambotte, O., Luo, M., Mallal, S., van Manen, D., Martinez-Picado, J., Meyer, L., Miro, J.M., Mullins, J.I., Obel, N., O'Brien, S.J., Pereyra, F., Plummer, F.A., Poli, G., Qi, Y., Rucart, P., Sandhu, M.S., Shea, P.R., Schuitemaker, H., Theodorou, I., Vannberg, F., Veldink, J., Walker, B.D., Weintrob, A., Winkler, C.A., Wolinsky, S., Telenti, A., Goldstein, D.B., de Bakker, P.I.W., Zagury, J-F and Fellay, J. (2013) Association study of common genetic variants and HIV-1 acquisition in 6,300 infected cases and 7,200 controls. PLoS Pathogens, 9 (7). e1003515.

Bartha, I., Carlson, J.M., Brumme, C.J., McLaren, P.J., Brumme, Z.L., John, M., Haas, D.W., Martinez-Picado, J., Dalmau, J., Lopez-Galindez, C., Casado, C., Rauch, A., Günthard, H.F., Bernasconi, E., Vernazza, P., Klimkait, T., Yerly, S., O'Brien, S.J., Listgarten, J., Pfeifer, N., Lippert, C., Fusi, N., Kutalik, Z., Allen, T.M., Muller, V., Harrigan, P.R., Heckerman, D., Telenti, A. and Fellay, J. (2013) A genome-to-genome analysis of associations between human genetic variation, HIV-1 sequence diversity, and viral control. eLife, 2 . e01123-e01123.

Beecham, A.H., Patsopoulos, N.A., Xifara, D.K., Davis, M.F., Kemppinen, A., Cotsapas, C., Shah, T.S., Spencer, C., Booth, D., Goris, A., Oturai, A., Saarela, J., Fontaine, B., Hemmer, B., Martin, C., Zipp, F., D'Alfonso, S., Martinelli-Boneschi, F., Taylor, B., Harbo, H.F., Kockum, I., Hillert, J., Olsson, T., Ban, M., Oksenberg, J.R., Hintzen, R., Barcellos, L.F., Agliardi, C., Alfredsson, L., Alizadeh, M., Anderson, C., Andrews, R., Søndergaard, H.B., Baker, A., Band, G., Baranzini, S.E., Barizzone, N., Barrett, J., Bellenguez, C., Bergamaschi, L., Bernardinelli, L., Berthele, A., Biberacher, V., Binder, T.M.C., Blackburn, H., Bomfim, I.L., Brambilla, P., Broadley, S., Brochet, B., Brundin, L., Buck, D., Butzkueven, H., Caillier, S.J., Camu, W., Carpentier, W., Cavalla, P., Celius, E.G., Coman, I., Comi, G., Corrado, L., Cosemans, L., Cournu-Rebeix, I., Cree, B.A.C., Cusi, D., Damotte, V., Defer, G., Delgado, S.R., Deloukas, P., di Sapio, A., Dilthey, A.T., Donnelly, P., Dubois, B., Duddy, M., Edkins, S., Elovaara, I., Esposito, F., Evangelou, N., Fiddes, B., Field, J., Franke, A., Freeman, C., Frohlich, I.Y., Galimberti, D., Gieger, C., Gourraud, P-A, Graetz, C., Graham, A., Grummel, V., Guaschino, C., Hadjixenofontos, A., Hakonarson, H., Halfpenny, C., Hall, G., Hall, P., Hamsten, A., Harley, J., Harrower, T., Hawkins, C., Hellenthal, G., Hillier, C., Hobart, J., Hoshi, M., Hunt, S.E., Jagodic, M., Jelčić, I., Jochim, A., Kendall, B., Kermode, A., Kilpatrick, T., Koivisto, K., Konidari, I., Korn, T., Kronsbein, H., Langford, C., Larsson, M., Lathrop, M., Lebrun-Frenay, C., Lechner-Scott, J., Lee, M.H., Leone, M.A., Leppä, V., Liberatore, G., Lie, B.A., Lill, C.M., Linden, M., Link, J., Luessi, F., Lycke, J., Macciardi, F., Männistö, S., Manrique, C.P., Martin, R., Martinelli, V., Mason, D., Mazibrada, G., McCabe, C., Mero, I-L, Mescheriakova, J., Moutsianas, L., Myhr, K-M, Nagels, G., Nicholas, R., Nilsson, P., Piehl, F., Pirinen, M., Price, S.E., Quach, H., Reunanen, M., Robberecht, W., Robertson, N.P., Rodegher, M., Rog, D., Salvetti, M., Schnetz-Boutaud, N.C., Sellebjerg, F., Selter, R.C., Schaefer, C., Shaunak, S., Shen, L., Shields, S., Siffrin, V., Slee, M., Sorensen, P.S., Sorosina, M., Sospedra, M., Spurkland, A., Strange, A., Sundqvist, E., Thijs, V., Thorpe, J., Ticca, A., Tienari, P., van Duijn, C., Visser, E.M., Vucic, S., Westerlind, H., Wiley, J.S., Wilkins, A., Wilson, J.F., Winkelmann, J., Zajicek, J., Zindler, E., Haines, J.L., Pericak-Vance, M.A., Ivinson, A.J., Stewart, G., Hafler, D., Hauser, S.L., Compston, A., McVean, G., De Jager, P., Sawcer, S.J. and McCauley, J.L. (2013) Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nature Genetics, 45 (11). pp. 1353-1360.

Bellgard, M., Beroud, C., Parkinson, K., Harris, T., Ayme, S., Baynam, G., Weeramanthri, T., Dawkins, H. and Hunter, A. (2014) Correction: Dispelling myths about rare disease registry system development. Source Code for Biology and Medicine, 9 (1).

Bellgard, M., Beroud, C., Parkinson, K., Harris, T., Ayme, S., Baynam, G., Weeramanthri, T., Dawkins, H. and Hunter, A. (2013) Dispelling myths about rare disease registry system development. Source Code for Biology and Medicine, 8 (1). p. 21.

Bhattacharya, T., Daniels, M., Heckerman, D., Foley, B., Frahm, N., Kadie, C., Carlson, J., Yusim, K., McMahon, B., Gaschen, B., Mallal, S., Mullins, J.I., Nickle, D.C., Herbeck, J., Rousseau, C, Learn, G.H., Miura, T., Brander, C., Walker, B. and Korber, B. (2007) Founder effects in the assessment of HIV polymorphisms and HLA allele associations. Science, 315 (5818). pp. 1583-1586.

Bihl, F., Frahm, N., Di Giammarino, L., Sidney, J., John, M., Yusim, K., Woodberry, T., Sango, K., Hewitt, H.S., Henry, L., Linde, C.H., Chisholm, J.V., Zaman, T.M., Pae, E., Mallal, S., Walker, B.D., Sette, A., Korber, B.T., Heckerman, D. and Brander, C. (2006) Impact of HLA-B alleles, epitope binding affinity, functional avidity, and viral coinfection on the immunodominance of virus-specific CTL responses. Journal of Immunology, 176 (7). pp. 4094-101.

Black, L.J., Jacoby, P., She Ping-Delfos, W.C., Mori, T.A., Beilin, L.J., Olynyk, J.K., Ayonrinde, O.T., Huang, R.C., Holt, P.G., Hart, P.H., Oddy, W.H. and Adams, L.A. (2014) Low serum 25-hydroxyvitamin D concentrations associate with non-alcoholic fatty liver disease in adolescents independent of adiposity. Journal of Gastroenterology and Hepatology, 29 (6). pp. 1215-1222.

Broadley, S.A., Barnett, M.H., Boggild, M., Brew, B.J., Butzkueven, H., Heard, R., Hodgkinson, S., Kermode, A.G., Lechner-Scott, J., Macdonell, R.A.L., Marriott, M., Mason, D.F., Parratt, J., Reddel, S.W., Shaw, C.P., Slee, M., Spies, J., Taylor, B.V., Carroll, W.M., Kilpatrick, T.J., King, J., McCombe, P.A., Pollard, J.D. and Willoughby, E. (2014) Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 1 Historical and established therapies. Journal of Clinical Neuroscience, In press .

Broadley, S.A., Barnett, M.H., Boggild, M., Brew, B.J., Butzkueven, H., Heard, R., Hodgkinson, S., Kermode, A.G., Lechner-Scott, J., Macdonell, R.A.L., Marriott, M., Mason, D.F., Parratt, J., Reddel, S.W., Shaw, C.P., Slee, M., Spies, J., Taylor, B.V., Carroll, W.M., Kilpatrick, T.J., King, J., McCombe, P.A., Pollard, J.D. and Willoughby, E. (2014) Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 2 New and emerging therapies and their efficacy. Journal of Clinical Neuroscience, In press .

Brockman, M.A., Chopera, D.R., Olvera, A., Brumme, C.J., Sela, J., Markle, T.J., Martin, E., Carlson, J.M., Le, A.Q., McGovern, R., Cheung, P.K., Kelleher, A.D., Jessen, H., Markowitz, M., Rosenberg, E., Frahm, N., Sanchez, J., Mallal, S., John, M., Harrigan, P.R., Heckerman, D., Brander, C., Walker, B.D. and Brumme, Z.L. (2012) Uncommon pathways of immune escape attenuate HIV-1 integrase replication capacity. Journal of Virology, 86 (12). pp. 6913-6923.

Bronke, C., Almeida, C.M., McKinnon, E., Roberts, S.G., Keane, N.M., Chopra, A., Carlson, J.M., Heckerman, D., Mallal, S. and John, M. (2013) HIV escape mutations occur preferentially at HLA-binding sites of CD8 T-cell epitopes. AIDS, 27 (6). pp. 899-905.

Brusch, A.M., Clarke, R.C., Platt, P.R. and Phillips, E.J. (2014) Exploring the link between pholcodine exposure and neuromuscular blocking agent anaphylaxis. British Journal of Clinical Pharmacology, 78 (7). pp. 14-23.

Bull, R.A., Luciani, F., McElroy, K., Gaudieri, S., Pham, S.T., Chopra, A., Cameron, B., Maher, L., Dore, G.J., White, P.A. and Lloyd, A.R. (2011) Sequential bottlenecks drive viral evolution in early acute Hepatitis C virus infection. PLoS Pathogens, 7 (9). e1002243.

Carlson, J.M., Brumme, C.J., Martin, E., Listgarten, J., Brockman, M.A., Le, A.Q., Chui, C.K.S., Cotton, L.A., Knapp, D.J.H.F., Riddler, S.A., Haubrich, R., Nelson, G., Pfeifer, N., DeZiel, C.E., Heckerman, D., Apps, R., Carrington, M., Mallal, S., Harrigan, P.R., John, M. and Brumme, Z.L. (2012) Correlates of protective cellular immunity revealed by analysis of population-level immune escape pathways in HIV-1. Journal of Virology, 86 (24). pp. 13202-13216.

Chakera, A., Lucas, A. and Lucas, M. (2011) Surrogate markers of infection: interrogation of the immune system. Biomarkers in Medicine, 5 (2). pp. 131-148.

Chalmers, K.A., Knuiman, M.W., Divitini, M.L., Bruce, D.G., Olynyk, J.K. and Milward, E.A. (2012) Long-term mortality risks associated with mild anaemia in older persons: the Busselton Health Study. Age and Ageing, 41 (6). pp. 759-764.

Chaubey, S.K., Sinha, A.K., Phillips, E., Russell, D.B. and Falhammar, H. (2009) Transient cardiac arrhythmias related to lopinavir/ritonavir in two patients with HIV infection. Sexual Health, 6 (3). pp. 254-257.

Cheng, Y.-C., Anderson, C.D., Bione, S., Keene, K., Maguire, J.M., Nalls, M., Rasheed, A., Zeginigg, M., Attia, J., Baker, R., Barlera, S., Biffi, A., Bookman, E., Brott, T.G., Brown, R. D., Chen, F., Chen, W.-M., Ciusani, E., Cole, J.W., Cortellini, L., Danesh, J., Doheny, K., Ferrucci, L., Grazia Franzosi, M., Frossard, P., Furie, K.L., Golledge, J., Hankey, G.J., Hernandez, D., Holliday, E.G., Hsu, F.-C., Jannes, J., Kamal, A., Khan, M.S., Kittner, S.J., Koblar, S.A., Lewis, M., Lincz, L., Lisa, A., Matarin, M., Moscato, P., Mychaleckyj, J.C., Parati, E.A., Parolo, S., Pugh, E., Rost, N.S., Schallert, M., Schmidt, H., Scott, R.J., Sturm, J.W., Yadav, S., Zaidi, M., Boncoraglio, G.B., Levi, C.R., Meschia, J.F., Rosand, J., Sale, M., Saleheen, D., Schmidt, R., Sharma, P., Worrall, B. and Mitchell, B.D. (2012) Are myocardial infarction-associated single-nucleotide polymorphisms associated with ischemic stroke? Stroke, 43 (4). pp. 980-986.

Cherry, C.L., Nolan, D., James, I.R., McKinnon, E.J., Mallal, S.A., Gahan, M.E., Lal, L., McArthur, J.C. and Wesselingh, S.L. (2006) Tissue-specific associations between mitochondrial DNA levels and current treatment status in HIV-Infected individuals. JAIDS Journal of Acquired Immune Deficiency Syndromes, 42 (4). pp. 435-440.

Chikata, T., Carlson, J.M., Tamura, Y., Borghan, M.A., Naruto, T., Hashimoto, M., Murakoshi, H., Le, A.Q., Mallal, S., John, M., Gatanaga, H., Oka, S., Brumme, Z.L. and Takiguchi, M. (2014) Host-Specific adaptation of HIV-1 Subtype B in the Japanese population. Journal of Virology, 88 (9). pp. 4764-4775.

Chikata, T., Carlson, J.M., Tamura, Y., Brumme, Z.L., Naruto, T., Hashimoto, M., Borghan, M.A., John, M., Mallal, S., Gatanaga, H., Oka, S. and Yakiguchi, M. (2012) HLA-associated viral polymorphism in chronically HIV-1-infected Japanese cohort: analysis of four-digit HLA allele level. Retrovirology, 9 (Suppl 2).

Chopra, A. and Nanjundiah, V. (2013) The precision with which single cells of Dictyostelium discoideum can locate a source of cyclic AMP. Chaos, Solitons & Fractals, 50 . pp. 3-12.

Cotton, L., Chopera, D., Penney, K., Carlson, J., Martin, E., Le, A., Kuang, T., Walker, B., Fuchs, J., Buchbinder, S., Wagner, T., John, M., Mallal, S., Koblin, B., Mayer, K., Poon, A., Brockman, M. and Brumme, Z. (2012) Limited evidence for alterations in Gag-mediated HIV replication capacity over the course of the North American epidemic (1979-present). Retrovirology, 9 (Suppl 2). P157.

Côté, H.C.F., Gerschenson, M., Walker, U.A., Miro, O., Garrabou, G., Hammond, E.L., Villarroya, J., Giralt, M., Villarroya, F., Cinque, P., Garcia-Arumi, E., Andreu, A.L., Pinti, M. and Cossarizza, A. (2011) Quality assessment of human mitochondrial DNA quantification: MITONAUTS, an international multicentre survey. Mitochondrion, 11 (3). pp. 520-527.

D'Arminio Monforte, A., Abrams, D., Pradier, C., Weber, R., Reiss, P., Bonnet, F., Kirk, O., Law, M., De Wit, S., Friis-Moller, N., Phillips, A., Sabin, C., Lundgren, J. and Mallal, S. (2008) HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies. AIDS, 22 (16). pp. 2143-2153.

D'Orsogna, L.J., Nguyen, T.H.O., Claas, F.H.J., Witt, C. and Mifsud, N.A. (2013) Endogenous-peptide-dependent alloreactivity: new scientific insights and clinical implications. Tissue Antigens, 81 (6). pp. 399-407.

D'Orsogna, L.J., van den Heuvel, H., van der Meer-Prins, E.M.W., Roelen, D.L., Doxiadis, I.I.N. and Claas, F.H.J. (2012) Stimulation of human EBV-and CMV-specific cytolytic effector function using allogeneic HLA molecules. The Journal of Immunology, 189 (10). pp. 4825-4831.

Desmond, C.P., Bartholomeusz, A., Gaudieri, S., Revill, P.A. and Lewin, S.R. (2007) A systematic review of T-cell epitopes in hepatitis B virus: Identification, genotypic variation and relevance to antiviral therapeutics. Antiviral Therapy, 13 (2). pp. 161-175.

Desmond, C.P., Gaudieri, S., James, I.R., Pfafferott, K., Chopra, A., Lau, G.K., Audsley, J., Day, C., Chivers, S., Gordon, A., Revill, P.A., Bowden, S., Ayres, A., Desmond, P.V., Thompson, A.J., Roberts, S. K., Locarnini, S.A., Mallal, S.A. and Lewin, S.R. (2012) Viral adaptation to host immune responses occurs in chronic hepatitis B virus (HBV) infection, and adaptation is greatest in HBV e antigen-negative disease. Journal of Virology, 86 (2). pp. 1181-1192.

Dong, T., Zhang, Y., Xu, K. Y., Yan, H., James, I., Peng, Y., Blais, M.-E., Gaudieri, S., Chen, X., Lun, W., Wu, H., Qu, W. Y., Rostron, T., Li, N., Mao, Y., Mallal, S., Xu, X., McMichael, A., John, M. and Rowland-Jones, S. L. (2011) Extensive HLA-driven viral diversity following a narrow-source HIV-1 outbreak in rural China. Blood, 118 (1). pp. 98-106.

Duracinsky, M., Herrmann, S., Berzins, B., Armstrong, A.R., Kohli, R., Le Coeur, S., Diouf, A., Fournier, I., Schechter, M. and Chassany, O. (2012) The development of PROQOL-HIV: An international instrument to assess the health-related quality of life of persons living with HIV/AIDS. JAIDS Journal of Acquired Immune Deficiency Syndromes, 59 (5). pp. 498-505.

Duracinsky, M., Lalanne, C., Goujard, C., Herrmann, S., Cheung-Lung, C., Brosseau, J -P, Schwartz, Y. and Chassany, O. (2014) Electronic versus paper-based assessment of health-related quality of life specific to HIV disease: Reliability study of the PROQOL-HIV questionnaire. Journal of Medical Internet Research, 16 (4).

Duracinsky, M., Lalanne, C., Le Coeur, S., Herrmann, S., Berzins, B., Armstrong, A.R., Fai Lau, J.T., Fournier, I. and Chassany, O. (2012) Psychometric validation of the PROQOL-HIV questionnaire, a new health-related quality of life instrument–specific to HIV disease. JAIDS Journal of Acquired Immune Deficiency Syndromes, 59 (5). pp. 506-515.

Dwyer, B.J., Olynyk, J.K., Ramm, G.A. and Tirnitz-Parker, J.E.E. (2014) TWEAK and LTβ signaling during chronic liver disease. Frontiers in Immunology, 5 .

Falster, K., Petoumenos, K., Chuah, J., Mijch, A., Mulhall, B., Kelly, M., Cooper, D.A. and Mallal, S. (2009) Poor baseline immune function predicts an incomplete immune response to combination antiretroviral treatment despite sustained viral suppression. JAIDS Journal of Acquired Immune Deficiency Syndromes, 50 (3). pp. 307-313.

Fellay, J., Ge, D., Shianna, K.V., Colombo, S., Ledergerber, B., Cirulli, E.T., Urban, T.J., Zhang, K., Gumbs, C.E., Smith, J. P., Castagna, A., Cozzi-Lepri, A., De Luca, A., Easterbrook, P., Günthard, H.F., Mallal, S., Mussini, C., Dalmau, J., Martinez-Picado, J., Miro, J.M., Obel, N., Wolinsky, S.M., Martinson, J.J., Detels, R., Margolick, J.B., Jacobson, L.P., Descombes, P., Antonarakis, S.E., Beckmann, J.S., O'Brien, S.J., Letvin, N.L., McMichael, A.J., Haynes, B.F., Carrington, M., Feng, S., Telenti, A., Goldstein, D.B. and McCarthy, M.I. (2009) Common genetic variation and the control of HIV-1 in humans. PLoS Genetics, 5 (12). e1000791.

Flanagan, D., MacLellan, D., Gibbs, H., Baker, R. and Fletcher, J. (2008) The insidious hazard of hospitalisation: Venous thromboembolism. Medicine Today, 9 (9). pp. 16-26.

Gabutero, E., Moore, C., Mallal, S., Stewart, G. and Williamson, P. (2007) Interaction between allelic variation in IL12B and CCR5 affects the development of AIDS: IL12B/CCR5 interaction and HIV/AIDS. AIDS, 21 (1). pp. 65-69.

Gaudieri, S. (2011) Biomarkers that reflect immune activation or dysfunction will be important in the management of infectious diseases. Biomarkers in Medicine, 5 (2). pp. 109-112.

Gaudieri, S., Lucas, M., Lucas, A., McKinnon, E., Albloushi, H., Rauch, A., di Iulio, J., Martino, D., Prescott, S.L. and Tulic, M.K. (2012) Genetic variations in IL28B and allergic disease in children. PLoS ONE, 7 (1). e30607.

Gaudieri, S., Tulic, M.K., Lucas, A. and Lucas, M. (2012) IFN-λ and IgE-mediated allergic disease: A potential future role? Biomarkers in Medicine, 6 (2). pp. 151-157.

Goot, K., Hazeldine, S., Bentley, P., Olynyk, J. and Crawford, D. (2012) Elevated serum ferriti: What should GPs know? Australian Family Physician, 41 (12). pp. 945-949.

Haas, D.W., Kuritzkes, D.R., Ritchie, M.D., Amur, S., Gage, B.F., Maartens, G., Masys, D., Fellay, J., Phillips, E., Ribaudo, H.J., Freedberg, K.A., Petropoulos, C., Manolio, T.A., Gulick, R.M., Haubrich, R., Kim, P., Dehlinger, M., Abebe, R. and Telenti, A. (2011) Pharmacogenomics of HIV therapy: Summary of a workshop sponsored by the National Institute of Allergy and Infectious Diseases. HIV Clinical Trials, 12 (5). pp. 277-285.

Ham, S., Meachem, S.J., Choong, C.S., Charles, A.K., Baynam, G.S., Jones, T.W., Samarajeewa, N.U., Simpson, E.R. and Brown, K.A. (2013) Overexpression of aromatase associated with loss of heterozygosity of the STK11 gene accounts for prepubertal gynecomastia in boys with Peutz-Jeghers Syndrome. Journal of Clinical Endocrinology & Metabolism, 98 (12). E1979-E1987.

Hammond, E., Lucas, A., Lucas, M., Phillips, E. and Gaudieri, S. (2010) Vaniprevir: HCV NS3/4A protease inhibitor treatment of hepatitis C. Drugs of the Future, 35 (10). pp. 803-813.

Hammond, E., McKinnon, E., Glendenning, P., Williams, R., Mallal, S. and Phillips, E. (2012) Association between 25-OH vitamin D and insulin is independent of lipoatrophy in HIV. Clinical Endocrinology, 76 (2). pp. 201-206.

Hazeldine, S., Trinder, D. and Olynyk, J.K. (2013) Non-Hfe iron overload: Is Phlebotomy the answer? Current Hepatitis Reports, 12 (1). pp. 20-27.

Herrmann, R., Thom, J., Wood, A., Phillips, M, Muhammad, S. and Baker, R. (2013) Thrombin generation using the calibrated automated thrombinoscope to assess reversibility of dabigatran and rivaroxaban. Thrombosis and Haemostasis, 111 (5). pp. 989-995.

Herrmann, S., McKinnon, E., Hyland, N.B., Lalanne, C., Mallal, S., Nolan, D., Chassany, O. and Duracinsky, M. (2013) HIV-related stigma and physical symptoms have a persistent influence on health-related quality of life in Australians with HIV infection. Health and Quality of Life Outcomes, 11 (1).

Herrmann, S., Wardrop, J., John, M., Gaudieri, S., Lucas, M., Mallal, S. and Nolan, D. (2012) The impact of visa status and Medicare eligibility on people diagnosed with HIV in Western Australia: a qualitative report. Sexual Health, 9 (5). p. 407.

Herrmann, S.E., McKinnon, E.J., Williams, L.J., John, M., Mallal, S., Lucas, M. and Nolan, D.A. (2010) Use of alcohol, nicotine and other drugs in the Western Australian HIV Cohort study. Sexual Health, 9 (2). pp. 199-201.

Hertz, T., Nolan, D., James, I., John, M., Gaudieri, S., Phillips, E.J., Huang, J.C., Riadi, G., Mallal, S. and Jojic, N. (2011) Mapping the Landscape of Host-Pathogen Coevolution: HLA Class I Binding and Its Relationship with Evolutionary Conservation in Human and Viral Proteins. Journal of Virology, 85 (3). pp. 1310-1321.

Hertz, T., Oshansky, C., Roddam, P., DeVincenzo, J., Caniza, M., Jojic, N., Mallal, S., Phillips, E., James, I., Thomas, P., Halloran, M. and Corey, L. (2013) HLA targeting efficiency correlates with human T cell response magnitude and with mortality from influenza A infection. The Journal of Immunology, 190 (Supp. 1). 49.21.

Hertz, T., Oshansky, C.M., Roddam, P.L., DeVincenzo, J.P., Caniza, M.A., Jojic, N., Mallal, S., Phillips, E., James, I., Halloran, M.E., Thomas, P.G. and Corey, L. (2013) HLA targeting efficiency correlates with human T-cell response magnitude and with mortality from influenza A infection. Proceedings of the National Academy of Sciences, 110 (33). pp. 13492-13497.

House, M.J., Bangma, S.J., Thomas, M., Gan, E.K., Ayonrinde, O.T., Adams, L.A., Olynyk, J.K. and St. Pierre, T.G. (2013) Texture-based classification of liver fibrosis using MRI. Journal of Magnetic Resonance Imaging . In Press.

House, M.J., Gan, E.K., Adams, L.A., Ayonrinde, O.T., Bangma, S.J., Bhathal, P.S., Olynyk, J.K. and St. Pierre, T.G. (2013) Diagnostic performance of a rapid magnetic resonance imaging method of measuring hepatic steatosis. PLoS ONE, 8 (3). e59287.

Huang, R-C, Beilin, L.J., Ayonrinde, O., Mori, T.A., Olynyk, J.K., Burrows, S., Hands, B. and Adams, L.A. (2013) Importance of cardiometabolic risk factors in the association between nonalcoholic fatty liver disease and arterial stiffness in adolescents. Hepatology, 58 (4). pp. 1306-1314.

John, M., Heckerman, D., James, I., Park, L.P., Carlson, J.M., Chopra, A., Gaudieri, S., Nolan, D., Haas, D.W., Riddler, S.A., Haubrich, R. and Mallal, S. (2010) Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs. The Journal of Immunology, 184 (8). pp. 4368-4377.

Johnson, L., James, I., Rodrigues, J., Stell, R., Thickbroom, G. and Mastaglia, F. (2013) Clinical and posturographic correlates of falling in Parkinson's disease. Movement Disorders, 28 (9). pp. 1250-1256.

Johnstone, D., Riveros, C., Heidari, M., Graham, R., Trinder, D., Berretta, R., Olynyk, J., Scott, R., Moscato, P. and Milward, E. (2013) Evaluation of different normalization and analysis procedures for illumina gene expression microarray data involving small changes. Microarrays, 2 (2). pp. 131-152.

Karlin, E. and Phillips, E. (2014) Genotyping for severe drug hypersensitivity. Current Allergy and Asthma Reports, 14 (3).

Keane, N., Almeida, C., Chopra, A., Cooper, D., Demaine, E., Mallal, S. and John, M. (2012) Early changes in the CD8 T Cell immunodominance hierarchy in primary HIV infection prior to seroconversion. Retrovirology, 9 (Suppl 2).

Keane, N., Almeida, C., Roberts, S., Ahmad, I., Mallal, S. and John, M. (2012) Evaluation of the dual IFNγ/IL-2 fluorospot-assay with flow cytometry for detection of HLA-restricted HIV-specific T-cell responses in HIV controllers. Retrovirology, 9 (Suppl 2). P243.

Keane, N.M. and John, M. (2011) Biomarkers of natural and vaccine immunity against HIV. Biomarkers in Medicine, 5 (2). pp. 113-116.

Keane, N.M., Roberts, S.G., Almeida, C.M., Krishnan, T., Chopra, A., Demaine, E., Laird, R., Tschochner, M., Carlson, J.M., Mallal, S., Heckerman, D., James, I. and John, M. (2012) High-avidity, high-IFNγ-producing CD8 T-cell responses following immune selection during HIV-1 infection. Immunology and Cell Biology, 90 (2). pp. 224-234.

Kostenko, L., Kjer-Nielsen, L., Nicholson, I., Hudson, F., Lucas, A., Foley, B., Chen, K., Lynch, K., Nguyen, J., Wu, A.H.B., Tait, B.D., Holdsworth, R., Mallal, S., Rossjohn, J., Bharadwaj, M. and McCluskey, J. (2011) Rapid screening for the detection of HLA-B57 and HLA-B58 in prevention of drug hypersensitivity. Tissue Antigens, 78 (1). pp. 11-20.

Kruger, P.C., Leahy, M.F. and Olynyk, J.K. (2012) Assessing iron overload: Are we there yet? Clinical Cancer Research, 18 (23). pp. 6395-6397.

Law, M.G., Woolley, I., Templeton, D.J., Roth, N., Chuah, J., Mulhall, B., Canavan, P., McManus, H., Cooper, D.A., Petoumenos, K. and Nolan, D. (2011) Trends in detectable viral load by calendar year in the Australian HIV observational database. Journal of the International AIDS Society, 14 (1). pp. 10-16.

Li, H., Blair, L., Chen, Y., Learn, G., Pfafferott, K., John, M., Bhattacharya, T., Hahn, B.H., Mallal, S., Shaw, G.M. and Bar, K.J. (2013) Molecular mechanisms of HIV Type 1 prophylaxis failure revealed by Single-genome sequencing. Journal of Infectious Diseases, 208 (10). pp. 1598-1603.

Lippert, E., Girodon, F., Hammond, E., Jelinek, J., Reading, N.S., Fehse, B., Hanlon, K., Hermans, M., Richardson, C., Swierczek, S., Ugo, V., Carillo, S., Harrivel, V., Marzac, C., Pietra, D., Sobas, M., Mounier, M., Migeon, M., Ellard, S., Kroger, N., Herrmann, R., Prchal, J.T., Skoda, R.C. and Hermouet, S. (2009) Concordance of assays designed for the quantification of JAK2V617F: a multicenter study. Haematologica, 94 (1). pp. 38-45.

Lucas, M. and Gaudieri, S. (2012) The interferon family as biomarkers of disease: renaissance of the innate immune system. Biomarkers in Medicine, 6 (2). pp. 133-135.

Luo, Y-B and Mastaglia, F.L. (2014) Dermatomyositis, polymyositis and immune-mediated necrotising myopathies. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, In press .

Luo, Y-B, Mastaglia, F.L. and Wilton, S.D. (2014) Normal and aberrant splicing of LMNA. Journal of Medical Genetics, 51 (4). pp. 215-223.

Luo, Y-B, Mitrpant, C., Adams, A.M., Johnsen, R.D., Fletcher, S., Mastaglia, F.L. and Wilton, S.D. (2014) Antisense oligonucleotide induction of progerin in human myogenic cells. PLoS ONE, 9 (6).

Luo, Y-B, Mitrpant, C., Johnsen, R., Fabian, V., Needham, M., Fletcher, S., Wilton, S.D. and Mastaglia, F.L. (2013) Investigation of splicing changes and post-translational processing of LMNA in sporadic inclusion body myositis. International Journal of Clinical and Experimental Pathology, 6 (9). pp. 1723-1733.

Luquetti, D., Claes, P., Liberton, D.K., Daniels, K., Rosana, K.M., Quillen, E.E., Pearson, L.N., McEvoy, B., Bauchet, M., Zaidi, A.A., Yao, W., Tang, H, Barsh, G.S., Absher, D.M., Puts, D.A., Rocha, J., Beleza, S., Pereira, R.W., Baynam, G., Suetens, P., Vandermeulen, D., Wagner, J.K., Boster, J.S. and Shriver, M.D. (2014) Modeling 3D Facial Shape from DNA. PLoS Genetics, 10 (3). e1004224.

Ma, M.X., John, M. and Forbes, G.M. (2013) Diagnostic dilemmas in celiac disease. Expert Review of Gastroenterology & Hepatology, 7 (7). pp. 643-655.

Maker, G.L., Siva, B., Batty, K.T, Trengove, R.D., Ferrari, P. and Olynyk, J.K. (2013) Pharmacokinetics and safety of deferasirox in subjects with chronic kidney disease undergoing haemodialysis. Nephrology, 18 (3). pp. 188-193.

Mallal, S. and Phillips, E. (2012) Abacavir and the altered peptide repertoire model: Clinical implications. Journal of the International AIDS Society, 15 (6(Suppl 4)). p. 18119.

Mallal, S., Phillips, E., Carosi, G., Molina, J-M, Workman, C., Tomazic, J., Jagel-Guedes, E., Rugina, S., Kozyrev, O., Cid, J.F., Hay, P., Nolan, D., Hughes, S., Hughes, A., Ryan, S., Fitch, N., Thorborn, D. and Benbow, A. (2008) HLA-B*5701 screening for hypersensitivity to Abacavir. The New England Journal of Medicine, 358 (6). pp. 568-579.

Martin, A., Amin, J., Cooper, D.A., Carr, A., Kelleher, A.D., Bloch, M., Baker, D., Woolley, I., Emery, S. and Nolan, D. (2010) Abacavir does not affect circulating levels of inflammatory or coagulopathic biomarkers in suppressed HIV: A randomized clinical trial. AIDS, 24 (17). pp. 2657-2663.

Martin, A.M., Krueger, R., Almeida, C.A., Nolan, D., Phillips, E. and Mallal, S. (2006) A sensitive and rapid alternative to HLA typing as a genetic screening test for abacavir hypersensitivity syndrome. Pharmacogenetics and Genomics, 16 (5). pp. 353-357.

Martínez, E. and Nolan, D. (2008) Long-term management of the HIV-infected patient - Tailoring highly active antiretroviral therapy to optimise therapeutic outcome. European Infectious Diseases, 2 (2). pp. 16-22.

Mastaglia, F.L., Rojana-udomsart, A., James, I., Needham, M., Day, T.J., Kiers, L., Corbett, J.A., Saunders, A.M., Lutz, M.W. and Roses, A.D. (2013) Polymorphism in the TOMM40 gene modifies the risk of developing sporadic inclusion body myositis and the age of onset of symptoms. Neuromuscular Disorders, 23 (12). pp. 969-974.

McGettigan, B.D., Hew, M., Phillips, E. and McLean-Tooke, A. (2012) Sulphadiazine-induced renal stones in a 63-year-old HIV-infected man treated for toxoplasmosis. BMJ: Case Reports, 2012 (21 Sept 2012).

McKenzie, E.J., Taylor, P., Stillion, R.J., Lucas, A.D., Harris, J., Gordon , S. and Martinez-Pomares, L. (2007) Mannose receptor expression and function define a new population of murine dendritic cells. Journal of Immunology, 178 (8). pp. 4975-4983.

McKinnon, E.J., Rossi, E., Beilby, J.P., Trinder, D. and Olynyk, J.K. (2014) Factors that affect serum levels of ferritin in Australian adults and implications for Follow-up. Clinical Gastroenterology and Hepatology, 12 (1). pp. 101-108.

Merani, S., Petrovic, D., James, I., Chopra, A., Cooper, D., Freitas, E., Rauch, A., di Iulio, J., John, M., Lucas, M., Fitzmaurice, K., McKiernan, S., Norris, S., Kelleher, D., Klenerman, P. and Gaudieri, S. (2011) Effect of immune pressure on hepatitis C virus evolution: Insights from a single-source outbreak. Hepatology, 53 (2). pp. 396-405.

Nakano, H., Chua, A.C.G., Klopcic, B.R.S., Ho, D.S., Fu, S.K., Forrest, C.H., Croft, K.D., Olynyk, J.K., Lawrance, I.C. and Trinder, D. (2013) Dietary iron enhances colonic inflammation and IL-6/IL-11-Stat3 signaling promoting colonic tumor development in mice. PloS one, 8 (11). e78850.

Nitschke, K., Barriga, A., Schmidt, J., Timm, J., Viazov, S., Kuntzen, T., Kim, A.Y., Lauer, G.M., Allen, T.M., Gaudieri, S., Rauch, A., Lange, C.M., Sarrazin, C., Eiermann, T., Sidney, J., Sette, A., Thimme, R., López, D. and Neumann-Haefelin, C. (2013) HLA-B∗27 subtype specificity determines targeting and viral evolution of a hepatitis C virus-specific CD8+ T cell epitope. Journal of Hepatology, 60 (1). pp. 22-29.

Nolan, D., Castley, A., Tschochner, M., James, I., Qiu, W., Sayer, D., Christiansen, F.T., Witt, C., Mastaglia, F., Carroll, W. and Kermode, A. (2012) Contributions of vitamin D response elements and HLA promoters to multiple sclerosis risk. Neurology, 79 (6). pp. 538-546.

Oddy, W.H., Herbison, C.E., Jacoby, P., Ambrosini, G.L., O'Sullivan, T.A., Ayonrinde, O.T., Olynyk, J.K., Black, L.J., Beilin, L.J., Mori, T.A., Hands, B.P. and Adams, L.A. (2013) The western dietary pattern is prospectively associated with non-alcoholic fatty liver disease in adolescence. The American Journal of Gastroenterology, 108 (5). pp. 778-785.

Ostrov, D.A., Grant, B.J., Pompeu, Y.A., Sidney, J., Harndahl, M., Southwood, S., Oseroff, C., Lu, S., Jakoncic, J., de Oliveira, C.A.F., Yang, L., Mei, H., Shi, L., Shabanowitz, J., English, A.M., Wriston, A., Lucas, A., Phillips, E., Mallal, S., Grey, H.M., Sette, A., Hunt, D.F., Buus, S. and Peters, B. (2012) Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire. Proceedings of the National Academy of Sciences, 109 (25). pp. 9959-9964.

Pavlos, R., Mallal, S., Ostrov, D., Pompeu, Y. and Phillips, E. (2014) Fever, rash, and systemic symptoms: Understanding the role of virus and HLA in severe cutaneous drug allergy. The Journal of Allergy and Clinical Immunology: In Practice, 2 (1). pp. 21-33.

Pavlos, R., Mallal, S. and Phillips, E. (2012) HLA and pharmacogenetics of drug hypersensitivity. Pharmacogenomics, 13 (11). pp. 1285-1306.

Pavlos, R. and Phillips, E.J. (2012) Individualization of antiretroviral therapy. Pharmacogenomics and Personalized Medicine, 5 (1). pp. 1-17.

Payne, R.P., Branch, S., Kloverpris, H., Matthews, P.C., Koofhethile, C.K., Strong, T., Adland, E., Leitman, E., Frater, J., Ndung'u, T., Hunter, E., Haubrich, R., Mothe, B., Edwards, A., Riddell, L., Chen, F., Harrigan, P.R., Brumme, Z.L., Mallal, S., John, M., Jooste, J.P., Shapiro, R., Deeks, S.G., Walker, B.D., Brander, C., Landis, C., Carlson, J.M., Prado, J.G. and Goulder, P.J.R. (2014) Differential escape patterns within the dominant HLA-B*57:03-restricted HIV gag epitope reflect distinct Clade-Specific functional constraints. Journal of Virology, 88 (9). pp. 4668-4678.

Pett, S.L., Wand, H., Law, M.G, Arduino, R., Lopez, J.C., Knysz, B., Pereira, L.C., Pollack, S., Reiss, P., Tambussi, G. and Mallal, S. (2006) Evaluation of subcutaneous proleukin (Interleukin-2) in a randomized international trial (ESPRIT): Geographical and gender differences in the baseline characteristics of participants. HIV Clinical Trials, 7 (2). pp. 70-85.

Pfafferott, K., Gaudieri, S., Ulsenheimer, A., James, I., Heeg, M., Nolan, D., John, M., Rauch, A., Mallal, S., Lucas, A.D., Klenerman, P., Diepolder, H.M. and Lucas, M. (2011) Constrained pattern of viral evolution in acute and early HCV infection limits viral plasticity. PLoS ONE, 6 (2). e16797.

Phillips, E.J. and Mallal, S. (2009) HLA and drug-induced toxicity. Current Opinion in Molecular Therapeutics, 11 (3). pp. 231-242.

Phillips, E.J. and Mallal, S. (2009) Personalizing antiretroviral therapy: is it a reality? Personalized Medicine, 6 (4). pp. 393-408.

Phillips, E.J. and Mallal, S. (2010) Pharmacogenetics of drug hypersensitivity. Pharmacogenomics, 11 (7). pp. 973-987.

Phillips, E. (2013) Antiretroviral therapy. Internal Medicine Journal, 43 . pp. 11-12.

Phillips, E., Bartlett, J.A., Sanne, I., Lederman, M.M., Hinkle, J., Rousseau, F., Dunn, D., Pavlos, R., James, I., Mallal, S.A. and Haas, D.W. (2013) Associations between HLA-DRB1*0102, HLA-B*5801, and hepatotoxicity during initiation of nevirapine-containing regimens in South Africa. JAIDS Journal of Acquired Immune Deficiency Syndromes, 62 (2). e55-e57.

Phillips, E., Hayden, A., Gutiérrez, S., Jahnke, N., Yip, B., Lima, V.D., Hogg, R.S., Harrigan, P.R. and Montaner, J.S.G. (2008) Is nevirapine-based therapy discontinuation in hepatitis C co-infected patients a more important mortality determinant than hypersensitivity: Authorsʼ reply. AIDS, 22 (4). pp. 548-549.

Phillips, E., Nolan, D. and Mallal, S. (2008) The Authors reply - Response to Vandekerckhove et al & Abel et al. New England Journal of Medicine, 358 (23). pp. 2515-2516.

Phillips, E.J., Chung, W-H, Mockenhaupt, M., Roujeau, J-C and Mallal, S. (2011) Drug hypersensitivity: Pharmacogenetics and clinical syndromes. Journal of Allergy and Clinical Immunology, 127 (3). S60-S66.

Phillips, E.J. and Mallal, S. (2007) Drug hypersensitivity in HIV. Current Opinion in Allergy and Clinical Immunology, 7 (4). pp. 324-330.

Phillips, E.J. and Mallal, S.A. (2011) HLA-B*1502 Screening and toxic effects of carbamazepine. New England Journal of Medicine, 365 (7). pp. 672-673.

Phillips, E.J. and Mallal, S.A. (2013) HLA-B*5701 and flucloxacillin associated drug-induced liver disease. AIDS, 27 (3). pp. 491-492.

Phillips, E.J. and Mallal, S.A. (2008) Pharmacogenetics and the potential for the individualization of antiretroviral therapy. Current Opinion in Infectious Diseases, 21 (1). pp. 16-24.

Plauzolles, A., Lucas, M. and Gaudieri, S. (2013) Hepatitis C virus adaptation to T-cell immune pressure. The Scientific World Journal, 2013 . pp. 1-7.

Pompeu, Y.A., Stewart, J.D., Mallal, S., Phillips, E., Peters, B. and Ostrov, D.A. (2012) The structural basis of HLA-associated drug hypersensitivity syndromes. Immunological Reviews, 250 (1). pp. 158-166.

Qiu, W., Pham, K., James, I., Nolan, D., Castley, A., Christiansen, F.T., Czarniak, P., Luo, Y., Wu, J., Garlepp, M., Wilton, S., Carroll, W.M., Mastaglia, F.L. and Kermode, A.G. (2013) The influence of non-HLA gene polymorphisms and interactions on disease risk in a Western Australian multiple sclerosis cohort. Journal of Neuroimmunology, 261 (1-2). pp. 92-97.

Raboud, J., Lesosky, M., Sterling, S., Phillips, E.J., Walmsley, S. and Bayoumi, A. (2007) An Estimate of the proportion of symptoms reported in Self-administered questionnaires that are captured as adverse drug events in an observational database. HIV Clinical Trials, 8 (5). pp. 311-319.

Rath, S.R., Bartley, A., Charles, A., Powers, Neil, Baynam, G., Jones, T., Priest, J.R., Foulkes, W.D. and Choong, C.S.Y. (2014) Multinodular goiter in children: An important pointer to a germline DICER1 mutation. The Journal of Clinical Endocrinology & Metabolism, 99 (6). pp. 1947-1948.

Rauch, A., Gaudieri, S., Evison, J., Nolan, D., Cavassini, M., Weber, R., James, I. and Furrer, H. (2008) Low current and nadir CD4+ T-cell counts are associated with higher hepatitis C virus RNA levels in the Swiss HIV cohort study. Antiviral Therapy, 13 (3). pp. 455-60.

Rauch, A., Nolan, D., Martin, A., McKinnon, E., Almeida, C. and Mallal, S. (2006) Prospective genetic screening decreases the incidence of Abacavir hypersensitivity reactions in the Western Australian HIV cohort study. Clinical Infectious Diseases, 43 (1). pp. 99-102.

Rive, C.M., Bourke, J. and Phillips, E.J. (2013) Testing for drug hypersensitivity syndromes. Clinical Biochemist Reviews, 34 (1). pp. 15-38.

Rodríguez-Sáinz, C., Valor, L., Hernández, D.C., Gil, J., Carbone, J., Pascual-Bernaldez, M., Rodríguez-Alcántara, F., Martínez, I., Vicario, J.L., Mallal, S. and Fernández-Cruz, E. (2013) Flow cytometry analysis with a new FITC-Conjugated monoclonal antibody-3E12 for HLA-B*57:01 rapid screening in prevention of abacavir hypersensitivity in HIV-1–infected patients. HIV Clinical Trials, 14 (4). pp. 160-164.

Rojana-udomsart, A., Castley, A, James, I., Needham, M., Scott, A., Day, T., Kiers, L., Corbett, A., Sue, C., Martinez, P., Christiansen, F. and Mastaglia, F.L. (2012) G.P.63 High-resolution analysis of HLA-DRB1 alleles and diplotypes in an Australian inclusion body myositis cohort. Neuromuscular Disorders, 22 (9-10). pp. 853-854.

Rojana-udomsart, A., James, I., Castley, A., Needham, M., Scott, A., Day, T., Kiers, L., Corbett, A., Sue, C., Witt, C., Martinez, P., Christiansen, F. and Mastaglia, F. (2012) High-resolution HLA-DRB1 genotyping in an Australian inclusion body myositis (s-IBM) cohort: An analysis of disease-associated alleles and diplotypes. Journal of Neuroimmunology, 250 (1-2). pp. 77-82.

Saag, M., Balu, R., Phillips, E.J., Brachman, P., Martorell, C., Burman, W., Stancil, B., Mosteller, M., Brothers, C., Wannamaker, P., Hughes, A., Sutherland‐Phillips, D., Mallal, S. and Shaefer, M. (2008) High sensitivity of human leukocyte antigen–B*5701 as a marker for immunologically confirmed abacavir hypersensitivity in white and black patients. Clinical Infectious Diseases, 46 (7). pp. 1111-1118.

Sabin, C., D'Arminio Monforte, A., Friis-Moller, N., Weber, R., El-Sadr, W., Reiss, P., Kirk, O., Mercie, P., Law, M., De Wit, S., Pradier, C., Phillips, A., Lundgren, J. and Mallal, S. (2008) Changes over time in risk factors for cardiovascular disease and use of Lipid‐lowering drugs in HIV‐Infected individuals and impact on myocardial infarction. Clinical Infectious Diseases, 46 (7). pp. 1101-1110.

Sabin, C., Worm, S., Weber, R., Reiss, P., El-Sadr, W., Dabis, F., De Wit, S., Law, M., D'Arminio Monforte, A., Friis-Moller, N., Kirk, O., Pradier, C., Weller, I., Phillips, A., Lundgren, J. and Mallal, S. (2008) Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration. The Lancet, 371 (9622). pp. 1417-1426.

Shear, N.H., Milpied, B., Bruynzeel, D.P. and Phillips, E.J. (2008) A review of drug patch testing and implications for HIV clinicians. AIDS, 22 (9). pp. 999-1007.

Smyth, R.P., Schlub, T.E., Grimm, A.J., Waugh, C., Ellenberg, P., Chopra, A., Mallal, S., Cromer, D., Mak, J., Davenport, M.P. and Hahn, B.H. (2014) Identifying Recombination Hot Spots in the HIV-1 Genome. Journal of Virology, 88 (5). pp. 2891-2902.

Stone, S.F., Phillips, E.J., Wiese, M.D., Heddle, R.J. and Brown, S.G.A (2014) Immediate-type hypersensitivity drug reactions. British Journal of Clinical Pharmacology, 78 (1). pp. 1-13.

Strautins, K., Tschochner, M., James, I., Choo, L., Dunn, D., Pedrini, M., Kermode, A., Carroll, W. and Nolan, D. (2014) Combining HLA-DR risk alleles and anti-Epstein-Barr virus antibody profiles to stratify multiple sclerosis risks. Multiple Sclerosis Journal, 20 (3). pp. 286-294.

Suppiah, V., Gaudieri, S., Armstrong, N.J., O'Connor, K.S., Berg, T., Weltman, M., Abate, M.L., Spengler, U., Bassendine, M., Dore, G.J., Irving, W.L., Powell, E., Hellard, M., Riordan, S., Matthews, G., Sheridan, D., Nattermann, J., Smedile, A., Müller, T., Hammond, E., Dunn, D.S., Negro, F., Bochud, P-Y, Mallal, S., Ahlenstiel, G., Stewart, G.J., George, J. and Booth, D.R. (2011) IL28B, HLA-C, and KIR variants additively predict response to therapy in chronic Hepatitis C virus infection in a European cohort: A cross-sectional study. PLoS Medicine, 8 (9). e1001092.

Thin, L.W.Y., Lawrance, I.C., Spilsbury, K., Kava, J. and Olynyk, J.K. (2014) Detection of liver injury in IBD using transient elastography. Journal of Crohn's and Colitis, 8 (7). pp. 671-677.

Tirnitz-Parker, J., Glanfield, A., Olynyk, J. and Ramm, G. (2013) Iron and hepatic carcinogenesis. Critical Reviews in Oncogenesis, 18 (5). pp. 391-407.

Tirnitz-Parker, J.E.E., Olynyk, J.K. and Ramm, G.A. (2014) Role of TWEAK in coregulating liver progenitor cell and fibrogenic responses. Hepatology, 59 (3). pp. 1198-1201.

Trubiano, J. and Phillips, E. (2013) Antimicrobial stewardshipʼs new weapon? A review of antibiotic allergy and pathways to ‘de-labeling'. Current Opinion in Infectious Diseases, 26 (6). pp. 526-537.

Xu, W., li, R., Dai, Y., Wu, A., Wang, H., Cheng, C., Qiu, W., Lu, Z., Zhong, X., Shu, Y., Kermode, A.G. and Hu, X. (2013) IL-22 secreting CD4+ T cells in the patients with neuromyelitis optica and multiple sclerosis. Journal of Neuroimmunology, 261 (1-2). pp. 87-91.

Yagita, Y., Kuse, N., Kuroki, K., Gatanaga, H., Carlson, J. M., Chikata, T., Brumme, Z. L., Murakoshi, H., Akahoshi, T., Pfeifer, N., Mallal, S., John, M., Ose, T., Matsubara, H., Kanda, R., Fukunaga, Y., Honda, K., Kawashima, Y., Ariumi, Y., Oka, S., Maenaka, K. and Takiguchi, M. (2013) Distinct HIV-1 Escape Patterns Selected by Cytotoxic T Cells with Identical Epitope Specificity. Journal of Virology, 87 (4). pp. 2253-2263.

Conference Paper

Keane, N.M., Pfafferott, K., Cooper, D., Roberts, S.G., Chopra, A., Demaine, E., Krishnan, T., Mallal, S. and John, M. (2010) HIV-1 adaptation to early HLA restricted immune responses in acute heterosexual transmission. In: 22nd Annual Conference of the Australasian Society for HIV Medicine, 20 - 22 October 2010, Sydney, Australia

Lucas, A., Meyer-Pannwitt, V., McKinnon, E., Burrows, S., Rist, M., Leary, S., Lucas, M., Mallal, S. and Phillips, E. (2013) Abacavir impairs an HLA-B*5701-restricted CD8+ T Cell response to an immunodominant Epstein-Barr virus epitope. In: 20th Conference on Retroviruses and Opportunistic Infections (CROI 2013), 3 - 6 March 2013, Atlanta, Georgia

Mallal, S. (2004) HIV, Now a chronic disease. In: 29th Australian & New Zealand Intensive Care Society Annual Scientific Meeting on Intensive Care, 7 - 10 October 2004, Melbourne, VIC

Tschochner, M., Rohrbach, J., Cooper, D., Merani, S., Chopra, A., Witteck, A., Battegay, M., Furrer, H., Günthard, H., Mallal, S., Rauch, A. and Gaudieri, S. (2010) Characterisation of hepatitis C virus evolution in HIV/HCV coinfected individuals using deep sequencing technology: Relevance for new antiviral drugs and disease outcome. In: 22nd Annual Conference of the Australasian Society for HIV Medicine, 20 - 22 October 2010, Sydney, Australia

Conference Item

Almeida, C., Bronke, C., Roberts, S., Cooper, D., Corkery, M., McKinnon, E., Ahmad, I., Keane, N., Chopra, A., Mallal, S., John, M. and Heckerman, D. (2009) Identification of multiple novel HIV-specific T-cell epitopes using HLA-associated HIV polymorphisms. In: 39th Annual Scientific Meeting of the Australasian Society for Immunology 2009, 6 - 10 December 2009, Gold Coast, QLD.

Almeida, C., Bronke, C., Roberts, S., McKinnon, E., Keane, N., Chopra, A., Kadie, C., Carlson, J., Haas, D., Riddler, S., Haubrich, R., Heckerman, D., Mallal, S. and John, M. (2010) HIV-1 adaptation leads to inflation of the HIV-specific CD8 T-cell response against HLA-adapted variant epitopes. In: Annual Meeting. Australasian Society for Immunology 2010, 5 - 9 December 2010, Perth, Western Australia.

Armstrong, A., Duracinsky, M., Lalanne, C., de Silva, M., Jamal, L., Herrmann, S., Carrieri, P., Davril, J. and Chassany, O. (2011) A new framework for understanding the impact of hepatitis C and its treatment on quality of life. In: ISPOR 14th Annual European Congress, 5 - 8 November, Madrid, Spain.

Bourke, J., Pavlos, R., Hollingsworth, P., McLean-Tooke, A., Horimoto, N., O'Brien, V., Edward, E. and Phillips, E. (2012) Penicillin de-labelling in tertiary clinics: Safe and efficacious but incomplete effectiveness. In: ASCIA 23rd Annual Scientific Meeting, 5 - 8 September 2012, Wellington, New Zealand.

Chikata, T., Carlson, J.M., Tamura, Y., Brumme, Z.L., Naruto, T., Hashimoto, M., Borghan, M.A., John, M., Mallal, S., Gatanaga, H., Oka, S. and Takiguchi, M. (2012) HLA-associated viral polymorphism in chronically HIV-1-Infected Japanese cohort: Analysis of four-digit HLA allele level. In: AIDS Vaccine 2012, 9 - 12 September 2012, Boston, U.S.A.

Chopra, A., Deganaar, J., Rushton, B., Maiden, T., Keller, J., Park, P.L., Gaudieri, S., John, M. and Mallal, S. (2007) High throughput sequencing of full length HIV-1 genomes. In: 4th International AIDS Conference on HIV Pathogenesis, Treatment and Prevention, 22 - 25 July, Sydney, Australia.

Chopra, A., Watson, M., Cooper, D., Leary, S., John, M. and Mallal, S. (2009) High throughput long amplicon sequencing, assembly and reference mapping of HIV genome using the GS FLX sequencer. In: 21st Annual Conference of the Australasian Society for HIV Medicine (ASHM), 9 - 11 September, Brisbane, Australia.

Cotton, L., Chopera, D., Penney, K., Carlson, J., Martin, E., Le, A., Kuang, T., Walker, B., Fuchs, J., Buchbinder, S., Wagner, T., John, M., Mallal, S., Koblin, B., Mayer, K., Poon, A., Brockman, M. and Brumme, Z. (2012) Limited evidence for alterations in Gag-mediated HIV replication capacity over the course of the North American epidemic (1979-Present). In: AIDS Vaccine 2012, 9 - 12 September 2012, Boston, U.S.A.

Deshpande, P., Lucas, M., Brunt, S., Goulding, M., Hollingsworth, P. and Bundell, C. (2013) Low level autoantibodies are common in a general Australian population. In: Australasian Society of Clinical Immunology and Allergy (ASCIA) 24th Annual Scientific Meeting, 11 - 13 September 2013, Perth, Australia.

Gan, E.K., Olynyk, J.K., Marsh, J.A., Ayonrinde, O.T., Mori, T.A., Beilin, L.J. and Adams, L. (2012) Factors affecting liver elastography in community-based young adults in the Raine study. In: The Liver Meeting 2012: American Association for the Study of Liver Diseases (AASLD) 63rd Annual Meeting, 9 - 13 November 2013, Boston, MA.

Gan, E.K., Olynyk, J.K., Marsh, J.A., Ayonrinde, O.T., Mori, T.A., Beilin, L.J. and Adams, L. (2012) Liver stiffness as a novel marker of metabolic syndrome? In: The Liver Meeting 2012: American Association for the Study of Liver Diseases (AASLD) 63rd Annual Meeting, 9 - 13 November 2013, Boston, MA.

Gaudieri, S., Rauch, A., James, I., Pfafferott, K., Baker, R., Cheng, W., McCaughan, G., Shackel, N., Jeffrey, G., Mollinson, L., Mallal, S., Furrer, H., Günthard, H., Hirschel, B., Klenerman, P., Nolan, D., John, M. and Lucas, M. (2009) Co-localisation of hepatitis C virus drug-resistant mutations and immune-driven adaptations: Relevance to therapy outcome. In: 19th Annual Combined Biological Sciences Meeting 2009, 28 August 2009, Perth, Western Australia.

Gaudieri, S., Rauch, A., James, I., Pfafferott, K., Cheng, W., McCaughan, G., Jeffrey, G., Mollison, L., Furrer, H., Günthard, H., Hirschel, B., Klenerman, P., Mallal, S., Nolan, D., John, M. and Lucas, M. (2009) Divergent adaptation of Hepatitis C virus genotypes to HLA-restricted immune pressure: relevance to HCV infection and vaccine design. In: 16th International Symposium on Hepatitis C Virus & Related Viruses, 3 - 7 October 2009, Nice, France.

Gaudieri, S., Rauch, A., Pfafferott, K., Park, L. and Mallal, S. (2007) Limited overlap in HLA-associated viral diversity between hepatitis C virus genotypes 1 and 3. In: 4th Australian Virology Group Meeting, 9 - 13 December 2007, Fraser Island, Queensland.

Graham, R., Delima, R.D., Johnstone, D., Milward, E.A., Olynyk, J.K. and Trinder, D. (2013) Changes in gene expression of cholesterol metabolism pathways in mouse models of haemochromatosis. In: BioIron 2013, 14 - 18 April 2013, University College, London.

Hammond, E., Almeida, C., Mamotte, C., Nolan, D., Phillips, E., Schollaardt, T., Gill, M.J., Angel, J.B., Neurath, D., Li, J., Giulivi, T., McIntyre, C., Koultchitski, G., Wong, B., Reis, M., Rachlis, A., Cole, D.E., Chew, C.B., Neifer, S. and Mallal, S. (2007) Multi-centre evaluation of HLA-B*5701 allele detection by SSP-PCR typing: a quality assurance initiative. In: 4th International AIDS Conference on HIV Pathogenesis, Treatment and Prevention, 22 - 25 July, Sydney, Australia.

Harari, A., Cellerai, C., Kostler, J., Gaudieri, S., James, I., John, M., Wagner, R., Mallal, S. and Pantaleo, G. (2007) Relationship between HLA Genotype and the functional profile of Antigen-specific CD8 T cells. In: 14th Conference on Retroviruses and Opportunistic Infections, 25 - 28 February 2007, Los Angeles, U.S.A.

Herrmann, S., Duracinsky, M., Lalanne, C., Acquadro, C., Mallal, S. and Nolan, D. (2009) Health-related quality of life in the WA HIV Cohort: 2008. In: 21st Annual Conference of the Australasian Society for HIV Medicine (ASHM), 9 - 11 September, Brisbane, Australia.

Herrmann, S., John, M., Wardrop, J. and Nolan, D. (2011) Antiretroviral issues in temporary visa holders in Western Australia: A qualitative report on access, attitude and adherence. In: 23rd Annual Australasian Society for HIV Medicine Conference, 26 - 28 September, Canberra, Australia.

Herrmann, S., John, M., Wardrop, J. and Nolan, D. (2011) Experiences of people on temporary visas who are diagnosed with HIV in Western Australia. In: 23rd Annual Australasian Society for HIV Medicine Conference, 26 - 28 September, Canberra, Australia.

Herrmann, S., Lucas, M., John, M. and Nolan, D. (2011) Implementing medication adherence interventions into HIV clinical care: Implications for current research and other blood borne viruses. In: WA SiREN Research Symposium - Found or Lost in Translation, 6 May, Perth, Western Australia.

Herrmann, S., Williams, L., McKinnon, E. and Nolan, D. (2009) Substance use in the WA HIV Cohort: 2002-2008. In: 21st Annual Conference of the Australasian Society for HIV Medicine (ASHM), 9 - 11 September, Brisbane, Australia.

Herrmann, S., Williams, L., McKinnon, E. and Nolan, D. (2010) Vulnerable populations: Substance use in the WA HIV Cohort Study. In: 17th Western Australian Drug and Alcohol Symposium, 30 August - 1 September, Fremantle, Western Australia.

Hertz, T., Nolan, D., James, I., John, M., Gaudieri, S., Phillips, E., Huang, J., Riadi, G., Mallal, S. and Jojic, N. (2011) HLA class I binding and its relationship with evolutionary conservation in human proteins and viral proteomes. In: Keystone HIV Evolution Genomics & Pathogenesis, 20 - 25 March 2011, Whistler, British Columbia, Canada.

John, M., Heckerman, D., Park, L., Gaudieri, S., James, I., Nolan, D., Chopra, A., Riddler, S., Haubrich, R. and Mallal, S. (2007) Strong genome-wide HLA associated selection in HIV-1. In: 31st Annual Scientific Meeting of the Australasian and South East Asian Tissue Typing Association (ASEATTA) 2007, 14 - 16 November 2007, Fremantle, WA.

Keane, N., Lucas, A., Netto, J., Almeida, C., Martin, A., Marriott, D., Kelleher, A., Phillips, E., Nolan, D. and Mallal, S. (2007) Use of the ELISpot assay to detect abacavir- and nevirapine-induced IFN-g responses in PBMC from HIV-infected patients with abacavir or nevirapine hypersensitivity reactions. In: 4th International AIDS Conference on HIV Pathogenesis, Treatment and Prevention, 22 - 25 July, Sydney, Australia.

Keane, N.M., Almeida, C., Chopra, A., Cooper, D., Demaine, E., Mallal, S. and John, M. (2012) Early changes in the CD8 T cell immunodominance hierarchy in primary HIV infection prior to seroconversion. In: AIDS Vaccine 2012, 9 - 12 September 2012, Boston, U.S.A.

Keane, N.M., Almeida, C., Roberts, S., Ahmad, I., Mallal, S. and John, M. (2012) Evaluation of the dual IFNγ/IL-2 Fluorospot-assay with flow cytometry for detection of HLA-restricted HIV-specific T-cell responses in HIV controllers. In: AIDS Vaccine 2012, 9 - 12 September 2012, Boston, U.S.A.

Kostenko, L., Lucas, A., Kjer-Nielsen, L., Foley, B., Nicholson, I., Tait, B., Holdsworth, R., Rossjohn, J., Mallal, S. and McCluskey, J. (2007) A rapid and sensitive flow-based screening test for detection of HLA-B57 to avoid abacavir hypersensitivity. In: 4th International AIDS Conference on HIV Pathogenesis, Treatment and Prevention, 22 - 25 July, Sydney, Australia.

Lalanne, C., Armstrong, A.R., Herrmann, S., Chassany, O. and Duracinsky, M. (2011) How does health-related quality Of life relate to symptoms experienced in HIV patients treated with highly-active antiretroviral therapy? In: ISPOR 14th Annual European Congress, 5 - 8 November, Madrid, Spain.

Lalanne, C., Herrmann, S., Armstrong, A.R., Cheung-Lung, C., Schwartz, Y., Chassany, O. and Duracinsky, M. (2013) Paper-based and electronic assessment of health-related quality of life specific to HIV disease: A reliability study with the Proqol-HIV questionnaire. In: International Society for Pharmacoeconomics and Outcomes Research, 16th Annual European Congress, 2 - 6 November, Dublin, Ireland.

Lee, M.H., Anderson, J., Stocker, S.L., Williams, K.M., Graham, G.G., Phillips, E.J., Nolan, D. and Day, R.O. (2009) A tale of two brothers: A familial study of risk factors to allopurinol-induced Stevens-Johnson Syndrome. In: Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) Conference 2009, 29 November - 2 December 2009, Sydney Convention Centre, Sydney.

Lucas, A., Lucas, M., Mallal, S. and Phillips, E. (2010) Antigen specific CD8+T cells in abacavir hypersensitiviy can become oligoclonal, CD43Io+/-CD127hi. In: 40th Australasian Society of Immunology Annual Scientific Meeting, 5 - 9 December 2010, Perth, W.A.

Lucas, A., Lucas, M., Pavlos, R., Mallal, S. and Phillips, E. (2012) Abacavir reactive HLA-B*5701 restricted memory CD8+ T cells are present in abacavir unexposed donors. In: 19th Conference on Retroviruses and Opportunistic Infections (CROI 2012), 5 - 8 March, Seattle, Washington, USA.

Lucas, M., Pfafferott, K., Baker, R., Baccala, M., Herrmann, S. and Gaudieri, S. (2009) HCV-specific T-cell responses reflect Hepatitis C infection outcome following multiple exposures to the virus. In: Australian Centre for HIV & Hepatitis Virology Research (ACH2) 5th National Workshop, 3 - 5 June, Terrigal, NSW, Australia.

Lucas, M., Pfafferott, K., Baker, R., Cheng, W., Mollison, L., Baccala, M., Miczkova, S., Nazareth, S., Herrmann, S., Rauch, A. and Gaudieri, S. (2009) Correlates of infection outcome following multiple exposures to the Hepatitis C virus. In: 16th International Symposium on Hepatitis C Virus & Related Viruses, 3 - 7 October, Nice, France.

Mallal, S. (2011) Co-evolution of HLA and viruses. In: Joint Forefront Lecture by Dr. Simon Mallal and Dr. Elizabeth Phillips, 4 March 2011, St. Paul's Hospital, Vancouver, British Columbia.

Mallal, S. (2009) Pharmacogenetic testing for predicting at risk patients: Genotyping and flow cytometry of HLA-B. In: Annual Meeting of the American Association of Clinical Chemistry (AACC) 2009, 19 - 23 July 2009, Chicago, IL.

Mallal, S. (2010) The pharmacogenetics of drug hypersensitivity. In: 16th World Congress of Basic and Clinical Pharmacology, 17 - 23 July 2010, Copenhagen, Denmark.

Mallal, S., Hertz, T., John, M., Gaudieri, S. and James, I. (2008) Co-evolution of viruses and their human host: What it might teach us? In: Perth Immunology Group Meeting, 9 - 10 October 2008, Perth Western Australia.

Mallal, S., John, M., Gaudieri, S., Phillips, E. and Nolan, D. (2008) How might understanding of the co-evolution of HLA and viruses inform contemporary clinical issues. In: 20th Annual Australasian Society for HIV Medicine Conference, 17 - 20 September, Perth, Western Australia.

Mallal, S. and Phillips, E. (2012) Abacavir and the altered peptide repertoire model: Clinical implications. In: 11th International Congress on Drug Therapy in HIV Infection, 11 - 15 November 2012, Glasgow, Scotland.

Mallal, S., Phillips, E., Carosi, G., Molina, J-M, Workman, C., Tomazic, J., Jagel-Guedes, E., Rugina, S., Kozyrev, O., Flores, C.J., Hay, P., Nolan, D., Hughes, S., Hughes, A., Thorborn, D. and Benbow, A. (2007) PREDICT-1: a novel randomised prospective study to determine the clinical utility of HLA-B*5701 screening to reduce abacavir hypersensitivity in HIV-1 infected subjects. In: 4th International AIDS Conference on HIV Pathogenesis, Treatment and Prevention, 22 - 25 July, Sydney, Australia.

Martin, A., Nolan, D., Rauch, A., Almeida, C., McKinnon, E. and Mallal, S. (2005) Genetic screening for Abacavir hypersensitivity (ABC-HSR) in the Western Australian cohort: Prospective data and novel diagnostic approaches. In: 17th Annual Conference of the Australasian Society for HIV Medicine (ASHM 2005), 24 - 27 August 2005, Hobart, Tasmania.

Martin, A.M., Almeida, C., Nolan, D., Cameron, P., Purcell, A., Chessman, D., McCluskey, J., Phillips, E. and Mallal, S. (2005) Involvement of metabolic and immune responses in the pathogenesis of Abacavir hypersensitivity reaction. In: 17th Annual Conference of the Australasian Society for HIV Medicine (ASHM 2005), 24 - 27 August 2005, Hobart, Tasmania.

McCluskey, J., Chessman, D., Lethborg, T., Kostenko, L., Purcell, A.W., Kjer-Nielsen, L., Mifsud, N.A., Tait, B.D., Holdsworth, R., Almeida, C., Nolan, D., Mallal, S., Bharadwaj, M. and Rossjohn, J. (2007) Abacavir hypersensitivity in HLA-B57-positive individuals with HIV infection is dependent upon the conventional MHC-I Ag presentation pathway. In: 4th International AIDS Conference on HIV Pathogenesis, Treatment and Prevention, 22 - 25 July, Sydney, Australia.

McGettigan, B.D., McKinnon, E., Mallal, S., French, M., Hammond, E., Nolan, D. and Phillips, E.J. (2010) Association between low 25(OH) vitamin D levels, antiretroviral therapy and metabolic profile in a cohort of treated ahd therapy naive HIV positive patients in Western Australia. In: 22nd Annual Conference of the Australasian Society for HIV Medicine, 20 - 22 October 2010, Sydney, Australia.

Nolan, D. and Mallal, S. (2009) EBV and MS: Lessons from hepatitis and HIV. In: 10th Biennial Scientific Conferene on "Progress on MS Research" - MSRA Conference 2009, 15 - 17 October 2009, Sydney, Australia.

Nolan, D., Thorborn, D., Shaefer, M., Laird, R., Montaner, M., Hughes, A., James, I., Mallal, S. and Phillips, E. (2008) Genetic factors predicting abacavir hypersensitivty and tolerance in HLA-B*5701 positive individuals: Combined analysis from PREDICT-1, SHAPE and a multinational study. In: 15th Conference on Retroviruses and Opportunistic Infections (CROI), 3 - 6 February 2008, Boston, U.S.A.

Pfafferott, K., Gaudieri, S., Ulsenheimer, A., John, M., James, I., Heeg, M., Nolan, D., Rauch, A., Lucas, A., Klenerman, P., Diepolder, H.M. and Lucas, M. (2009) Divergent pattern of viral evolution and escape dynamics in acute and early HCV and HIV infection. In: Australasian Virology Group Meeting, 13 - 17 December 2009, Mantra Erskine Resort, Lorne, VIC.

Pfafferott, K., Merani, S., Rauch, A., Baccala, M., Mallal, S., Baker, R., Gaudieri, S. and Lucas, M. (2010) One step closer to a CTL-based HCV vaccine. In: The Australian Centre for HIV and Hepatitis Virology Research (ACH2) 6th National Workshop, 23 - 25 June 2010, Yarra Valley, Australia.

Pfafferott, K., Ulsenheimer, A., Naidoo, K., Rauch, A., Gaudieri, S., Mallal, S., Diepolder, H. and Lucas, M. (2007) Longitudinal analysis of HLA Class I -driven adaptation of HCV: New insights into HCV escape dynamics. In: 4th Australian Virology Group Meeting, 9 - 13 December 2007, Fraser Island, Queensland.

Pfafferott, K., Ulsenheimer, A., Naidoo, K., Rauch, A., Gaudieri, S., Mallal, S., Diepolder, H.M. and Lucas, M. (2007) Genetic analysis of Hepatitis C (HCV) in acutely infected patients-evidence of limited HLA class II-driven selection pressure. In: 3rd Australian Centre for HIV & Hepatitis Research (ACH2) Workshop, 8 - 10 October 2007, Melbourne, Australia.

Phillips, E. (2011) Immunogenetics and immunopathology of drug hypersensitivity. In: Joint Forefront Lecture by Dr. Simon Mallal and Dr. Elizabeth Phillips, 4 March 2011, St. Paul's Hospital, Vancouver, British Columbia.

Phillips, E., Keane, N., Blyth, C., Lucas, A., Pavlos, R., Lucas, M., McKinnon, E. and Mallal, S. (2011) Both HLA Class I restricted CD8+ and Class II restricted CD4+T Cells are implicated in the pathogenesis of nevirapine hypersensitivity. In: 51st Interscience Conference of Antimicrobial Agents and Chemotherapy, 17 - 20 September 2011, Chicago, IL.

Phillips, E., Lucas, M., Keane, N., Lucas, A., McKinnon, E. and Mallal, S. (2010) HLA-B*35 is associated with nevirapine hypersensitivity in the contemporary western australian HIV cohort study. In: 4th International Drug Hypersensitivity Meeting, 22 - 25 April 2010, Rome, Italy.

Phillips, E., Nolan, D., Thorborn, D., Schaefer, M., Laird, R., Rauch, A., Rachlis, A., Shear, N., Knowles, S., Hughes, A., Montaner, J., James, I. and Mallal, S. (2008) Genetic factors predicting abacavir hypersensitivity and tolerance in HLA-B*5701 positive individuals. In: 3rd International Drug Hypersensitivity Conference, 11 - 13 April 2008, Paris, France.

Phillips, E., Rauch, A., Nolan, D., Martin, A., Almeida, C., Knowles, S., Shear, N., Cavassini, M., Harrigan, R., Montaner, J., Keane, N., Laird, R., Lucas, A. and Mallal, S. (2007) Genetic characterization of patients with MHC class I mediated abacavir hypersensitivity reaction. In: 4th International AIDS Conference on HIV Pathogenesis, Treatment and Prevention, 22 - 25 July, Sydney, Australia.

Phillips, E., Rauch, A., Nolan, D., Martin, A., Almeida, C., Laird, R., Montaner, J., Shear, N., Lucas, A. and Mallal, S. (2007) Genetic characterization of patch test negative patients reporting symptoms after initiation after abacavir. In: 8th International Workshop on Clinical Pharmacology of HIV Therapy, 16 - 18 April 2007, Budapest, Hungary.

Phillips, E., Stasezewski, S., Arribas, J., Fitch, N. and Givens, N. (2007) Characteristics of abacavir hypersensitivity diagnoses according to HLA-B*5701 status and subsequent abacavir patch test result. In: 11th European AIDS Conference, 24 - 27 October 2007, Madrid, Spain.

Phillips, E.J. (2009) Drugs that cause hypersensitivity reactions: Personalising medicine & Predicting the unpredictable. In: Annual Meeting of the American Association of Clinical Chemistry (AACC) 2009, 19 - 23 July 2009, Chicago, IL.

Phillips, E.J. (2009) Overcoming the barrier of clinical translation: The Abacavir example. In: Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) Conference 2009, 29 November - 2 December 2009, Sydney Convention Centre, Sydney.

Rauch, A., Thurnheer, C., Fux, C., Nolan, D., Cavassini, M., Chave, J-P, Opravil, M., Phillips, E., Mallal, S. and Furrer, H. (2008) Genetic testing and structured clinical assessment reveal over diagnosis of abacavir hypersensitivity reactions in the Swiss HIV Cohort Study. In: 12th International Workshop on HIV Observational Databases, 27 - 30 March 2008, Malaga, Spain.

Roberts , S., Almeida, C., Bronke, C., Ahmad, I., Keane, N., Chopra, A., Mallal, S., John, M., Heckerman, D. and Mallal, S. (2009) Screening for HIV responses using optimal epitopes predicted by HLA-viral sequence polymorphism associations. In: 21st Annual Conference of the Australasian Society for HIV Medicine (ASHM), 9 - 11 September, Brisbane, Australia.

Saag, M., Balu, R., Brachman, P., Brothers, C., Stancil, B., Mosteller, M., Wannamaker, P., Sutherland‐Phillips, D., Phillips, E., Mallal, S. and Shaefer, M. (2007) High sensitivity of HLA-B*5701 in Whites and Blacks in immunologically-confirmed cases of abacavir hypersensitivity (ABC HSR). In: 4th International AIDS Conference on HIV Pathogenesis, Treatment and Prevention, 22 - 25 July, Sydney, Australia.

Seet, J.M., Ingram, P.R., Lie, K., Phillips, E.J. and Murray, R.J. (2012) Using antibiotics better: The healthy antimicrobial prescribing initiative (HAPI). In: Australian Society for Antimicrobials 13th Annual Scientific Meeting, 23 - 25 February 2012, Brisbane Convention & Exhibition Centre, Brisbane.

Shasha, D., Meseret, Y., Chopra, A., Cooper, D., James, I., Herrmann, S., Wolday, D., Maayan, S., Mallal, S. and John, M. (2012) Unique footprints of HLA class I on clade C HIV-1 in a cohort of Ethiopian patients. In: 19th Conference on Retroviruses and Opportunistic Infections (CROI 2012), 5 - 8 March, Seattle, Washington, USA.

Tschochner, M., James , I., Almeida, C., Keane, N., Roberts, S., Bronke, C., Chopra, A., Maiden, T., Ahmad, I., Gaudieri, S., Mallal, S., Rauch, A., John, M., Furrer, H. and Günthard, H. (2009) Effects of HIV-1 immune selection on susceptability to integrase inhibitor resistance. In: 12th European AIDS Conference (EACS) 2009, 11 - 14 November 2009, Cologne, Germany.

Book Chapter

Nolan, D., Almeida, C., Phillips, E. and Mallal, S. (2007) Abacavir hypersensitivity. In: Pichler, W.J., (ed.) Drug Hypersensitivity. S. Karger AG, Basel, Switzerland, pp. 95-104.

Nolan, D., Mallal, S. and Reiss, P. (2012) Complications resulting from antiretroviral therapy for HIV infection. In: Volberding, P., Greene, W., Lange, J.M.A., Gallant, J.E. and Sewankambo, N., (eds.) Sande's HIV/AIDS Medicine: Medical Management of AIDS 2013. Elsevier Inc., pp. 177-191.

Phillips, E.J. and Mallal, S.A. (2010) Abacavir. In: Wu, A.H.B. and Kiang-Teck, J.Y., (eds.) Pharmacogenomic Testing in Current Clinical Practice. Humana Press, New York, U.S.A, pp. 201-212.

Phillips, E.J. and Mallal, S.A. (2010) HLA and drug reactions. In: Mehra, N.K., Kaur, G., McCluskey, J., Christiansen, F.T. and Claas, F.H.J., (eds.) The HLA Complex in Biology and Medicine: A Resource Book. Jaypee Brothers Medical Publishers (P) Ltd, New Delhi, India, pp. 332-349.

Thesis

Herrmann, Susan (2013) By virtue of circumstance: HIV/AIDS in mobile and rural populations in Western Australia, an ethnographic study. PhD thesis, Murdoch University.

Reeves, Karyn (2013) Founder effects and related issues in Host-viral association studies. PhD thesis, Murdoch University.

This list was generated on Tue Jul 22 18:30:46 2014 IST.